openPR Logo
Press release

Shingles Vaccines Market Surges as Global Demand for Preventive Healthcare Accelerates 2025 | DataM Intelligence

09-04-2025 08:01 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Shingles Vaccines Market

Shingles Vaccines Market

Market Overview:

The Shingles Vaccines Market is estimated to reach at a CAGR of 10.00% during the forecast period 2024-2031.

Shingles Vaccines Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/shingles-vaccines-market?sz

The Shingles Vaccines Market refers to the global industry focused on developing, producing, and distributing vaccines that prevent shingles (herpes zoster), a painful viral infection caused by the reactivation of the varicella-zoster virus. This market is driven by the growing elderly population, rising awareness of preventive healthcare, and increasing government immunization programs to reduce shingles-related complications.

Industry News of USA and Japan:

USA:

July 16, 2025: FDA approved Shingrix in a prefilled syringe to make administration easier.

June 5, 2025: Major pharmaceutical announced expanded distribution of a next-generation shingles vaccine.

Japan:

June 21, 2025: Government added latest recombinant zoster vaccine to national immunization for seniors over 50.

April 2, 2025: Long-term data supported broader Shingrix use, buttressing its label.

Key Players:

GlaxoSmithKline plc.
Merck & Co., Inc.
SK chemicals
Green Cross Corp
Geneone Life Science
Vaccitech
CanSinoBIO.

Growth Forecast Projected:

The Global Shingles Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Shingles Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=shingles-vaccines-market

Market Segmentation:

By Product: Shingrix, Zostavax, SKYZoster.

By Vaccine Type: Recombinant Vaccine, Live Attenuated Vaccine.

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/shingles-vaccines-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Shingles Vaccines market?

➠ Who are the leading manufacturers in the global Shingles Vaccines industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Shingles Vaccines industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Shingles Vaccines market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Shingles Vaccines Market Surges as Global Demand for Preventive Healthcare Accelerates 2025 | DataM Intelligence here

News-ID: 4169130 • Views:

More Releases from DataM Intelligence 4Market Research

Global Bioprocess Validation Market Set for Rapid Growth: Innovations and Opportunities Transforming Biopharmaceutical Industry 2025 | DataM Intelligence
Global Bioprocess Validation Market Set for Rapid Growth: Innovations and Opport …
Market Size and Growth: The Bioprocess Validation Market size was valued at USD 224,687.30 million in 2021 and is estimated to reach a CAGR of 11.20% over the forecast period 2024 to 2031. Bioprocess Validation Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of
Mucus Clearance Devices Market Set to Soar: Innovations Driving Patient Care and Market Growth in 2025 | DataM Intelligence
Mucus Clearance Devices Market Set to Soar: Innovations Driving Patient Care and …
Market Size and Growth: The Mucus Clearance Devices Market size was valued at USD 582.3 million in 2021 and is estimated to reach at a compound annual growth rate (CAGR) of 5.90% over the forecast period 2024-2031 Mucus Clearance Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed
Theranostics Market Set to Revolutionize Personalized Medicine: Growth, Trends, and Opportunities 2025 | DataM Intelligence
Theranostics Market Set to Revolutionize Personalized Medicine: Growth, Trends, …
Market Size and Growth: Theranostics Market reached USD 1.8 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global theranostics market is expected to exhibit a CAGR of 11.3% during the forecast period 2024-2031. Theranostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM
Liver Cancer Therapeutics Market Set to Surge: Innovative Treatments Driving Global Growth and Investment Opportunities 2025 | DataM Intelligence
Liver Cancer Therapeutics Market Set to Surge: Innovative Treatments Driving Glo …
Market Overview: The Global Liver Cancer Therapeutics market is expected to grow at a CAGR Of 11.70% during the forecast period 2024-2031. Liver Cancer Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion